|Videos|May 25, 2023
Interview with Rentschler Biopharma's Federico Pollano
Author(s)Rentschler Biopharma
KEY LEARNING OBJECTIVES
- Viewers will gain a clear understanding of Rentschler Biopharma’s US offering currently and in the near future
- Viewers will understand what sets Rentschler Biopharma apart from other CDMOs in the field
- Viewers will gain a good feel for what it is like to be a client of Rentschler Biopharma
Related Content
Trending on Pharmaceutical Technology
1
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
2
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
3
CPHI Milan 2026: AI and Bioavailability, Part 1
4
The Risk File Was Never Meant to Be a Once-a-Year Exercise
5